Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 open-label TAS-116 monotherapy in refractory GIST
jRCT2080223127Phase 2Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pimitespib in gastrointestinal stromal tumor (GIST), sponsored by Taiho Pharmaceutical Co., Ltd. Started Mar 2016; status: completed.
02
Drugs
pimitespib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on jRCT2080223127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223127.